GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)

Market Cap	425.01B
Revenue (ttm)	37.05B
Net Income (ttm)	8.59B
Shares Out	169.41M
EPS (ttm)	50.71
PE Ratio	49.47
Forward PE	43.49
Dividend	32.00 (1.28%)
Ex-Dividend Date	Nov 7, 2024

Volume	10,554
Average Volume	22,623
Open	2,583.15
Previous Close	2,569.45
Day's Range	2,487.55 - 2,586.00
52-Week Range	1,825.05 - 3,087.95
Beta	0.24
RSI	66.58
Earnings Date	Feb 10, 2025

About BOM:500660

GlaxoSmithKline Pharmaceuticals Limited manufactures, distributes, and trades in pharmaceuticals in India and internationally. The company offers vaccines, such as Infanrix Hexa for vaccination of infants against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and disease caused by Haemophilus influenzae type B; Synflorix for active immunization of infants against pneumococcal diseases and acute otitis media; Havrix for active immunization against disease caused by Hepatitis A virus; Menveo to prevent invasive meningococcal disease;...

• Industry: Pharmaceutical Preparations
• Founded: 1924
• Employees: 3,211
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 500660

Financial Performance

In 2023, BOM:500660's revenue was 34.54 billion, an increase of 6.21% compared to the previous year's 32.52 billion. Earnings were 5.90 billion, a decrease of -3.39%.